After Protracted Sell-Off, Amphastar Looks Like A Value Pick (NASDAQ:AMPH)

Group 1 - The article discusses Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) and its previous recommendation as a buy due to expected growth from the acquisition of BAQSIMI [1] - Despite the positive outlook, the stock did not perform well due to market pessimism surrounding the healthcare industry [1] Group 2 - The author has extensive experience in investment analysis, focusing on deep-discount value plays and underappreciated companies [1]